Assay of procarboxypeptidase U, a novel determinant of the fibrinolytic cascade, in human plasma

Clinical Chemistry

Volumn 45, Issue 6 I, 1999, Pages 807-813

  Schatteman, Katinka A ^a   Goossens, Filip J ^a   Scharpé, Simon S ^b   Neels, Hugo M ^b   Hendriks, Dirk F ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b Medical Research OCMW   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYPEPTIDASE; ENZYME PRECURSOR;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME PURIFICATION; FIBRINOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; PLASMA; REFERENCE VALUE;

EID: 0032992086     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.6.807     Document Type: Article

References (33)

1. Hendriks D, Scharpé S, van Sande M. Partial purification and characterization of a new arginine carboxypeptidase from human serum [Abstract]. J Clin Chem Clin Biochem 1988;26:305.
2. Hendriks D, Scharpé S, van Sande M, Lommaert MP. A labile enzyme in fresh human serum interferes with the assay of carboxypeptidase N. Clin Chem 1989;35:177.
3. Hendriks D, Scharpé S, van Sande M, Lommaert MP. Characterization of a carboxypeptidase in human serum distinct from carboxypeptidase N. J Clin Chem Clin Biochem 1989;27:277-85.
4. Hendriks D, Wang W, Scharpé S, Lommaert M, van Sande M. Purification and characterization of a new arginine carboxypeptidase in human serum. Biochim Biophys Acta 1990;1034:86-92.
5. Campbell W, Okada H. An arginine specific carboxypeptidase generated in blood during coagulation or inflammation which is unrelated to carboxypeptidase N or its subunits. Biochem Biophys Res Commun 1989;162:933-9.
6. Campbell W, Yonezo K, Shinohara T, Okada H. An arginine carboxypeptidase generated during coagulation is diminished or absent in patients with rheumatoid arthritis. J Lab Clin Med 1990;115:610-2.
7. Eaton D, Malloy B, Tsai S, Henzel W, Drayna D. Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma. J Biol Chem 1991;266: 21833-8.
8. Tsai S, Drayna D. The gene encoding human plasma carboxypeptidase B (CPB2) resides on chromosome 13. Genomics 1992;14: 549-50.
9. Skidgel R. Basic carboxypeptidases: regulators of peptide hormone activity. Trends Pharm Sci 1988;9:299-304.
10. Geokas M, Wollesen F, Rinderknecht H. Radioimmunoassay for pancreatic carboxypeptidase B in human serum. J Lab Clin Chem 1974;84:574-83.
11. Delk A, Durie P, Fletcher T, Largman C. Radioimmunoassay of active pancreatic enzymes in sera from patients with acute pancreatitis. I. Active carboxypeptidase B. Clin Chem 1985;31: 1294-300.
12. Wang W, Hendriks D, Scharpé S. Carboxypeptidase U: a plasma carboxypeptidase with high affinity for plasminogen. J Biol Chem 1994;269:15937-44.
13. Vanhoof G, Wauters J, Schatteman K, Hendriks D, Goossens F, Bossuyt P, et al. The gene for human carboxypeptidase U (CPU) - a proposed novel regulator of plasminogen activation -maps to 13q14.11. Genomics 1996;38:454-5.
14. Bajzar L, Manuel R, Nesheim M. Purification and characterization of TAFI, a thrombin-activatable fibrinolysis inhibitor. J Biol Chem 1995;270:14477-84.
15. Redlitz A, Tan A, Eaton D, Plow E, Plasma carboxypeptidases as regulators of the plasminogen system. J Clin Investig 1995;96: 2534-8.
16. Bajzar L, Nesheim M, Tracy P. The profibrinolytic effect of protein C in clots formed from plasma is TAFI-dependent. Blood 1996; 88;2093-100.
17. Redlitz A, Nicolini F, Malycky J, Topol E, Plow E. Inducible carboxypeptidase activity: a role in clot lysis in vivo. Circulation 1996;93:1328-30.
18. Bajzar L, Morser J, Nesheim M, TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J Biol Chem 1996;271: 16603-8.
19. Suenson E, Lützen O, Thorsen S. Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis. Eur J Biochem 1984;140:513-22.
20. Fleury V, Anglés-Cano E. Characterization of the binding of plasminogen to fibrin surfaces: the role of carboxy-terminal lysines. Biochemistry 1991;30:7630-8.
21. Pannell R, Black J, Gurewich V, Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained. J Clin Investig 1988;81:853-9.
22. Sakharov D, Plow E, Rijken D. On the mechanism of the antifibrinolytic activity of plasma carboxypeptidase B. J Biol Chem 1997;272:14477-82.
23. Broze G, Higuchi D. Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma. Blood 1996;88:3815-25.
24. Broze G. Thrombin-dependent inhibition of fibrinolysis. Curr Opin Hematol 1996;3:390-4.
25. Minnema M, Friederich P, Levi M, von dem Borne P, Mosnier L, Meijers J, et al. Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI: in vivo evidence for a role of factor XI as an anti-fibrinolytic factor. J Clin Investig 1998;101:10-4.
26. Mosnier L, von dem Borne P, Meijers J, Bouma B. Plasma TAFI levels explain the variable clot lysis time in healthy individuals [Abstract]. Blood 1997;90:10.
27. Vogel AI. Practical organic chemistry. London: Longman, 1970: 584.
28. Deutsch D, Mertz E. Plasminogen: purification from human plasma by affinity chromatography. Science 1970;170:1095-6.
29. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem 1976;72:248-54.
30. Laemmli U. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
31. Hendriks D, Scharpé S, van Sande M. Assay of carboxypeptidase N activity in serum by liquid-chromatographic determination of hippuric acid. Clin Chem 1985;31:1936-9.
32. Boffa M, Wang W, Bajzar L, Nesheim M. Plasma and recombinant thrombin-activatable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties. J Biol Chem 1988;273:2127-35.
33. Dang Q, Vindigni A, Di Cera E. An allosteric switch controls the procoagulant and anticoagulant activities of thrombin. Proc Natl Acad Sci U S A 1995;92:5977-81.